Margetuximab conjugated-PEG-PAMAM G4 nano-complex: a smart nano-device for suppression of breast cancer
Tóm tắt
Breast cancer due to its high incidence and mortality is the second leading cause of death among females. On the other hand, nanoparticle-based drug delivery is one of the most promising approaches in cancer therapy, nowadays. Hence, margetuximab- and polyethylene glycol-conjugated PAMAM G4 dendrimers were efficiently synthesized for targeted delivery of quercetin (therapeutic agent) to MDA-MB-231 breast cancer cells. Synthesized nano-complexes were characterized using analytical devices such as FT-IR, TGA, DLS, Zeta potential analyzer, and TEM. The size less than 40 nm, – 18.8 mV surface charge, efficient drug loading capacity (21.48%), and controlled drug release (about 45% of drug release normal pH after 8 h) were determined for the nano-complex. In the biomedical test, the cell viability was obtained 14.67% at 24 h of post-treatment for 800 nM concentration, and IC50 was ascertained at 100 nM for the nano-complex. The expression of apoptotic Bax and Caspase9 genes was increased by more than eightfolds and more than fivefolds after treatment with an optimal concentration of nanocarrier. Also, more than threefolds of cell cycle arrest was observed at the optimal concentration synthetics, and 27.5% breast cancer cell apoptosis was detected after treatment with 100 nM nano-complex. These outputs have been indicating the potential capacity of synthesized nano-complex in inhibiting the growth of breast cancer cells.
Tài liệu tham khảo
Narmani A, Yavari K, Mohammadnejad J. Imaging, biodistribution and in vitro study of smart 99mTc-PAMAM G4 dendrimer as novel nano-complex. Colloids Surf B. 2017;159:232–40.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019 (US statistics). CA Cancer J Clin. 2019;69:7–34.
DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Sauer AG, et al. Breast Cancer Statistics 2019. CA Cancer J Clin. 2019;69:438–51. https://doi.org/10.3322/caac.21583.
Study Forecasts New Breast Cancer Cases by 2030-National Cancer Institute. https://www.cancer.gov/news-events/cancer-currents-blog/2015/breast-forecast. Accessed 17 Mar 2020.
He Y, Liang Y, Mak JCW, Liao Y, Li T, Yan R, et al. Size effect of curcumin nanocrystals on dissolution, airway mucosa penetration, lung tissue distribution and absorption by pulmonary delivery. Colloids Surf B. 2020;186:110703.
Narmani A, Farhood B, Haghi-Aminjan H, Mortezazadeh T, Aliasgharzadeh A, Mohseni M, et al. Gadolinium nanoparticles as diagnostic and therapeutic agents: their delivery systems in magnetic resonance imaging and neutron capture therapy. J Drug Deliv Sci Technol. 2018;44:457–66.
Confeld MI, Mamnoon B, Feng L, Jensen-Smith H, Ray P, Froberg J, et al. Targeting the tumor core: hypoxia-responsive nanoparticles for delivery of chemotherapy to pancreatic tumors. Mol Pharm. 2020;17:2849–63.
Naderlou E, Salouti M, Amini B, Amini A, Narmani A, Jalilvand A, Shahbazi R, et al. Enhanced sensitivity and efficiency of detection of Staphylococcus aureus based on modified magnetic nanoparticles by photometric systems. Artif Cells Nanomed Biotechnol. 2020;48:810–7.
Karandish F, Mamnoon B, Feng L, Haldar MK, Xia L, Gange KN, et al. Nucleus-targeted, echogenic polymersomes for delivering a cancer stemness inhibitor to pancreatic cancer cells. Biomacromolecules. 2018;19:4122–32.
Narmani A, Kamali M, Amini B, Kooshki H, Amini A, Hassani L. Highly sensitive and accurate detection of Vibrio cholera O1 OmpW gene by fluorescence DNA biosensor based on gold and magnetic nanoparticles. Process Biochem. 2018;65:46–54.
Ding S, Khan AI, Cai X, Song Y, Lyu Z, Du D, et al. Overcoming blood–brain barrier transport: advances in nanoparticle-based drug delivery strategies. Mater Today. 2020;37:112–25.
Faramarzi N, Mohammadnejad J, Jafary H, Narmani A, Koosha M, Motlagh B. Synthesis and in vitro evaluation of tamoxifen-loaded gelatin as effective nano-complex in drug delivery systems. Int J Nanosci. 2020;19:2050002.
Yousefi M, Narmani A, Jafari SM. Dendrimers as efficient nanocarriers for the protection and delivery of bioactive phytochemicals. Adv Colloid Interface Sci. 2020;278:102125.
Laskar P, Somani S, Campbell SJ, Mullin M, Keating P, Tate RJ, et al. Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells. Nanoscale. 2019;11:20058–71.
Narmani A, Kamali M, Panahi Y, Amini B, Salimi A. Targeting delivery of oxaliplatin with smart PEG-modified PAMAM G4 to colorectal cell line: In vitro studies. Process Biochem. 2018;69:178–87.
Rezvani M, Mohammadnejad J, Narmani A, Bidaki K. Synthesis and in vitro study of modified chitosan polycaprolactam nano-complex as delivery system. Int J Biol Macromol. 2018;113:1287–93.
Chen Y, Wu D, Zhong W, Kuang S, Luo Q, Song L, et al. Evaluation of the PEG density in the PEGylated chitosan nanoparticles as a drug carrier for curcumin and mitoxantrone. Nanomaterials. 2018;8:486.
Narmani A, Arani MAA, Mohammadnejad J, Vaziri AZ, Solymani S, Yavari K, et al. Breast tumor targeting with PAMAM-PEG-5FU-99mTc as a new therapeutic nanocomplex: in in-vitro and in-vivo studies. Biomed. Microdevices. 2020;22:31.
Narmani A, Rezvani M, Farhood B, Darkhor P, Mohammadnejad J, Amini B, et al. Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems. Drug Dev Res. 2019;80:404–24.
Wang W, Zhou X, Bian Y, Wang S, Chai Q, Guo Z, et al. Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B. Nat Nanotechnol. 2020;15:406–16.
Mitri Z, Constantine T, O’Regan R. The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy. Chemother Res Pract. 2012; 2012:743193.
Bang YJ, Giaccone G, Im SA, Oh DY, Bauer TM, Nordstrom JL, et al. First-in-human Phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors. Ann Oncol. 2017;28:mdx002.
Gadag S, Sinha S, Nayak Y, Garg S, Nayak UY. Combination therapy and nanoparticulate systems: smart approaches for the effective treatment of breast cancer. Pharmaceutics. 2020;12:524.
Wang G, Wang JJ, Chen XL, Du L, Li F. Quercetin-loaded freeze-dried nanomicelles: improving absorption and anti-glioma efficiency in vitro and in vivo. J Control Release. 2016;235:276–90.
Khursheed R, Singh SK, Wadhwa S, Gulati M, Awasthi A. Enhancing the potential preclinical and clinical benefits of quercetin through novel drug delivery systems. Drug Discov Today. 2020;25:209–22.
Narmani A, Jafari SM. Chitosan-based nanodelivery systems for cancer therapy: recent advances. Carbohydr Polym. 2021;272:118464.
Zhu J, Xiong Z, Shen M, Shi X. Encapsulation of doxorubicin within multifunctional gadolinium-loaded dendrimer nano-complexes for targeted theranostics of cancer cells. RSC Adv. 2015;5:30286–96.
Narmani A, Mohammadnejad J, Yavari K. Synthesis and evaluation of polyethylene glycol- and folic acid-conjugated polyamidoamine G4 dendrimer as nanocarrier. J Drug Deliv Sci Technol. 2019;50:278–86.
Prieto MJ, del Rio Zabala NE, Marotta CH, Gutierrez HC, Arévalo RA, Chiaramoni NS, et al. Optimization and in vivo toxicity evaluation of G4.5 PAMAM dendrimer-risperidone complexes. PLoS ONE. 2014;9:e90393.
Mekuria SL, Tsai H-C. Preparation of self-assembled core-shell nano-structure of conjugated generation 4.5 poly (amidoamine) dendrimer and monoclonal anti-IL-6 antibody as bioimaging probe. Colloids Surf B. 2015;135:253–60.
Catauro M, Papale F, Bollino F, Piccolella S, Marciano S, Nocera P. Silica/quercetin sol–gel hybrids as antioxidant dental implant materials. Sci Technol Adv Mater. 2015;16:035001.
Hsu C, Chen SK, Chen WY, Tsai ML, Chen RH. Effect of the characters of chitosans used and regeneration conditions on the yield and physicochemical characteristics of regenerated products. Int J Mol Sci. 2015;16:8621–34.
Chen S, Yang K, Tuguntaev RG, Mozhi A, Zhang J, Wang PC, et al. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine: NBM. 2016;12:269–86.
Chang Y, Liu N, Chen L, Meng X, Liu Y, Li Y, et al. Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery. J Mater Chem. 2012;22:9594–601.
Ezzati Nazhad Dolatabadi J, Azami A, Mohammadi A, Hamishehkar H, Panahi-Azar V, Rahbar Saadat Y. A. Ata Saei, Formulation, characterization and cytotoxicity evaluation of ketotifen-loaded nanostructured lipid carriers. J Drug Deliv Sci Technol. 2018;46:268–73.
Li Y, Niu Y, Zhu J, Gao C, Xu Q, He Z, et al. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release. Nanoscale. 2020;12:2673–85.
Glassman PM, Myerson JW, Ferguson LT, Kiseleva RY, Shuvaev VV, Brenner JS. Targeting drug delivery in the vascular system: Focus on endothelium. Adv Drug Deliv Rev. 2020;157:96–117.
Gupta PK, Tripathi SK, Pappuru S, Chabattula SC, Govarthanan K, Gupta S. Metal-free semi-aromatic polyester as nanodrug carrier: A novel tumor targeting drug delivery vehicle for potential clinical application. Mater Sci Eng C. 2020;107:110285.
Lindenboim L, Grozki D, Amsalem-Zafran AR, Peña-Blanco A, Gundersen GG, Borner C, et al. Apoptotic stress induces Bax-dependent, caspase-independent redistribution of LINC complex nesprins. Cell Death Discovery. 2020;6:90.
Jiao C, Chen W, Tan X, Liang H, Li J, Yun H, et al. Ganoderma lucidum spore oil induces apoptosis of breast cancer cells in vitro and in vivo by activating caspase-3 and caspase-9. J Ethnopharmacol. 2020;247:112256.
Wang L, Zhou B–B, Yu K, Su Z–H, Gao S, Chu L–L, et al. Novel antitumor agent, trilacunary keggin–type tungstobismuthate, inhibits proliferation and induces apoptosis in human gastric cancer SGC–7901 cells. Inorg Chem. 2013;52:5119–27.
Mortezaee K, Narmani A, Salehi M, Bagheri H, Farhood B, Haghi-Aminjan H. Synergic effects of nanoparticles-mediated hyperthermia in radiotherapy/ chemotherapy of cancer. Life Sci. 2021;269:119020.
Paudel KR, Wadhwa R, Mehta M, Chellappan DK, Hansbro PM, Dua K. Rutin loaded liquid crystalline nanoparticles inhibit lipopolysaccharide induced oxidative stress and apoptosis in bronchial epithelial cells in vitro. Toxicol In Vitro. 2020;68:104961.